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Nickel is an essential metal for many archea,
bacteria, and plants (1), and may yet be found
to play a role in the metabolism of higher
organisms. Most bacteria and archea that can
live under anaerobic conditions (including
beneﬁcial bacteria in the human gut) produce
several enzymes that require Ni. Yet, under
some circumstances, Ni is a potent human
carcinogen (2,3). As potential speciﬁc molecu-
lar targets for carcinogenic Ni are identiﬁed, it
becomes possible to examine the structure of
these Ni sites for clues to how they give rise to
cancer. X-ray absorption spectroscopy (XAS)
is one technique that provides detailed struc-
tural information regarding biological Ni sites.
Analysis of Ni K-edge X-ray absorption near-
edge structure (XANES) produces informa-
tion regarding the coordination number and
geometry of a Ni site (4). Comparison of
shifts in Ni K-edge energies may reveal redox-
active Ni sites. The analysis of extended X-ray
absorption fine structure (EXAFS) provides
information regarding the types of ligands
bound to Ni and metric details for the Ni site
(5,6). The main goal of this research is to pro-
vide structural information regarding biologi-
cal Ni sites that are potentially involved in
carcinogenesis, and to elucidate the likely
properties that give rise to carcinogenesis by
comparing these structures with those of
Ni-containing biological molecules with
known functions.
Structure/Function
Relationships in Nickel
Metallobiochemistry
A variety of Ni-binding proteins and
Ni-dependent enzymes have been struc-
turally characterized (Figure 1). As with most
transition metals, the uptake, transport, stor-
age, intracellular concentration, and biosyn-
thesis of Ni metalloenzymes are tightly
regulated by proteins that specifically bind
Ni(II). These proteins include examples of
Ni-specific permeases (e.g., NixA, HoxN,
NikA–NikE) (7), metallochaperones (e.g.,
UreE, HypB, CooJ) (8–10), and proteins
involved in the regulation of biosynthesis
(e.g., NikR, H2 sensor) (11–13). One member
of this group of proteins has been crystallo-
graphically characterized. The metallochaper-
one UreE was recently shown to contain two
Ni-binding domains: a C-terminal polyhisti-
dine domain involved in storing Ni, and an
N-terminal domain that serves as a Ni chaper-
one to deliver Ni to the active site of urease
(14). A recent crystal structure of the N-termi-
nal domain with Cu2+ ions bound indicates
that pairs of His residues are involved in bind-
ing Ni in these sites (15). XAS studies of trun-
cated and holo proteins also reveal the
importance of His ligands in constructing
both the storage and chaperone sites (16–18).
An interesting example of Ni-specific
uptake and the regulation thereof is provided
by the Nik system in Escherichia coli (7,19).
The Nik system comprises five proteins
(NikA–NikE) that constitute a Ni-specific
ATP–dependent permease, and NikR, a tran-
scription factor that regulates the biosysthesis
of the Nik permease in response to intracellu-
lar Ni concentration (11,20,21). Of the five
proteins comprising the Nik permease, NikA
is known to play an important role both in
binding Ni and in Ni negative chemotaxis
(19,22–25). Deletion of the gene encoding
this protein eliminates Ni uptake and there-
fore the production of active hydrogenases
found in E. coli. The Ni-binding site in
NikA has been investigated by XAS, which
showed that the Ni bound to NikA is in a six-
coordinate environment featuring a combina-
tion of O/N-donor ligands (26). Given the
high carboxylic acid content of NikA and the
similarity of the XAS spectra to those
obtained from a model compound with car-
boxylate ligation, Ni(sal)2(OH2)2, the data
pointed to a structure with several carboxylate
ligands. A recent ﬁt of the EXAFS data using
multiple scattering theory shows that the data
are consistent with a site composed of two or
three His imidazole ligands and three or four
carboxylates (27).
The biosynthesis of the Nik permease is
regulated at the transcriptional level by Fnr
(fumarate nitrate regulatory protein), which
activates transcription in the absence of oxy-
gen, and by NikR, which represses the tran-
scription of the permease in response to high
(micromolar) concentrations of Ni in vitro
(11,21). Optimal transcription is thereby
achieved when the cells have a high demand
for Ni—under anaerobic conditions with low
concentrations of Ni.
NikR is a member of the ribbon–
helix–helix family of transcription factors
(20). These proteins feature homologous N-
terminal domains that bind to DNA, and can
have specialized C-terminal domains. The
details of the DNA-binding mechanism are
not completely understood. Of the known
ribbon–helix–helix transcription factors, NikR
is the only example that is known to respond
to metal concentration. NikR is a homod-
imeric protein that binds as a dimer of dimers
to a dyad-symmetric DNA-binding site con-
taining a GTATGA recognition sequence
repeated with separation of 16 bases. Proteins
with high sequence homology to E. coli NikR
have been identiﬁed in nine bacterial and six
archeal species. These proteins reveal the pres-
ence of six highly conserved residues
(H–X13–H–X10–H–X–H–X5–C–X–E) in the
C-terminal domain of NikR that are associ-
ated with the presence of a high-affinity
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Ni-binding site (kd < 3 pM). Binding of Ni to
the high-affinity sites induces a conforma-
tional change in the structure of NikR that
appears to be important in DNA binding.
However, because the dissociation constant of
this site is in the picomolar range, yet the pro-
tein represses transcription in response to
micromolar levels of Ni in vitro, a low-afﬁnity
site is implicated. Alternatively, the distribu-
tion of Ni in the cell may be under kinetic
control, in which case saturation of target Ni-
binding sites would be sensed by the high-
afﬁnity Ni-binding site in NikR. Preliminary
XAS analysis examining the high-affinity Ni
site indicates that the protein in the absence of
DNA has a planar four-coordinate Ni site
featuring two histidine ligands, one S-donor
ligand (presumably cysteine), and one other
O- or N-donor ligand. Thus, not all of the
conserved His residues are involved in form-
ing the high-afﬁnity site.
A predominance of His and carboxylate
ligation (Asp and Glu residues) is also found
in Ni enzymes that catalyze nonredox
processes. E. coli glyoxalase I catalyzes the iso-
merization of the hemimercaptal formed from
the nonenzymatic reaction of glutathione and
methylglyoxal into the thioester of D-lactate,
which is subsequently hydrolyzed. This pro-
vides a mechanism for the detoxification of
methylglyoxal by converting it to D-lactate.
Crystallographic and XAS data show that the
Ni site comprises two His, two Glu, and two
aqua/hydroxo ligands (6,28,29).
Urease provides another well-studied
example of the use of Ni in a nonredox
enzyme (30). Urease is a hydrolytic enzyme
that catalyzes the conversion of urea to ammo-
nium ion and carbamate. Here, a dinuclear Ni
site is bound to the protein by a combination
of four His ligands and a bidentate Asp
residue and bridged by a carbamate ligand
formed by posttranslational carbonylation of a
Lys residue (31). Each Ni is ﬁve or six coordi-
nate, with the remaining ligands derived from
water molecules in the active site (32–34).
In contrast to enzymes that catalyze nonre-
dox reactions, cysteine ligands play a dominant
role in constructing redox-active Ni sites, par-
ticularly those that use the formal Ni(III/II)
redox couple (Figure 1). Hydrogenases catalyze
the two-electron redox chemistry of H2. The
crystal structures of various hydrogenases reveal
that the Ni-containing hydrogenases have an
active-site Ni center ligated by four cysteines,
two of which bridge to the Fe atom in het-
erodinuclear active site (35,36). In the oxidized
forms of these enzymes, there is a third OH
bridging group that is lost upon reductive acti-
vation of the enzyme (37). The recent crystal
structures of Carboxydothermus hydrogenofor-
mans (38) and Rhodospirillum rubrum (39) car-
bon monoxide dehydrogenases, enzymes that
catalyzes the two-electron redox interconver-
sion of CO and CO2, reveal a NiFe4S5 active-
site cluster that incorporates a NiS4 center
formed by one cysteinato and three sulﬁdo lig-
ands. Superoxide dismutases catalyze the con-
version of superoxide ion to oxygen and
hydrogen peroxide using one-electron redox
chemistry. XAS studies of Ni superoxide dis-
mutase (NiSOD) from Streptomyces seoulensis
shows that the Ni center giving rise to the oxi-
dation and reduction of O2
– is ligated by three
S-donor ligands (40). This is true both for the
resting, oxidized state, which contains a ﬁve-
coordinate Ni center with one N-donor and
one N- or O-donor ligand in addition to the
S-donors, and for the reduced state, which has
a four-coordinate Ni site with only one non-S-
donor ligand. The amino acid sequence of this
enzyme reveals that the protein contains only
three S atoms corresponding to residues Cys2,
Cys6, and Met28. Although the involvement of
the Met residue in the NiSOD active site has
not been established, negatively charged S-
donor ligands (thiolate and sulﬁde) clearly sta-
bilize the potential of the Ni(III/II) redox
couple from over +1 V for aqueous Ni ions to
physiologically accessible redox potentials.
Nickel Carcinogenesis: A
Structure/Function View
The details of molecular mechanism(s) that
give rise to Ni carcinogenesis are not well
known. Studies of Ni toxicology and car-
cinogenesis reveal that Ni is predominantly
genotoxic and not mutagenic. These studies
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Figure 1. Examples of Ni complexes found in proteins and enzymes. The sketches are drawn using data
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also show that carcinogenic Ni compounds
selectively damage heterochromatin, leading to
chromatin condensation and enhanced DNA
methylation that silences reporter genes when
they are located near heterochromatin in yeast
or mammalian cells (41). There are several
ways in which Ni might gain entrance into the
cell. Soluble Ni compounds, which do not
appear to be the principle source of carcino-
genic Ni, could be transported into the cell via
the Mg2+ transport system because of the sim-
ilar charge/size ratio of the two metal ions.
However, the concentration of Ni that would
be required to effectively compete with Mg2+
transport is very high (mM) (2). Insoluble Ni
compounds have been demonstrated to enter
cells via endocytosis (3). The ability of Ni
compounds to transform cells has been corre-
lated to properties that increase endocytosis
(e.g., particle size, charge, and solubility).
Such a process is also consistent with the pre-
dominance of nasal and lung cancers caused
by inhalation of insoluble Ni compounds,
particularly Ni3S2, a potent carcinogen (2).
The endocytic vesicles formed may be acidi-
fied by fusion with lysosomes, ultimately
releasing large quantities of Ni ions into the
cytoplasm. Further, fusion of vesicles to the
nuclear membrane may deliver large quanti-
ties of Ni ions to the nucleus. Once in the
nucleus, potential gene silencing, DNA base
oxidation, DNA–protein cross-links, DNA
gaps or breaks, and histone hydrolysis could
potentially result from the interaction of Ni
with DNA, histones, and/or the generation of
reactive oxygen species via Ni redox chemistry
or indirect effects (2).
Because Ni2+ ions do not bind strongly to
DNA in competition with Mg2+, other biolog-
ical complexes of Ni are implicated, and com-
plexes formed with histone proteins are one
likely target. Nuclear histones have structures
consisting of globular C-terminal domains and
random-coil N-terminal domains (42–45).
The N-terminal tail regions are involved in
internucleosome contacts and are the site of
posttranslational modiﬁcation via acetylation,
which has been correlated with gene expres-
sion. Inspection of the amino acid sequence of
histones (46) does not reveal a large number of
potential metal-binding sites because of the
general lack of amino acid residues with side
chains bearing Lewis bases at physiological pH.
Histone H2A contains the –T120ESHHK–
sequence near the C-terminus (47). This site
has a glutamic acid and two histidine residues
that could engage in metal chelation. A second
potentially chelating site composed of cysteine
and histidine residues has been identified in
the C-terminal region of histone H3:
–C110AIH– (48,49). Last, a site near the N-
terminus of histone H4, –A15KRHRK–, has
also been proposed as a site for Ni binding
largely because of the inhibitory effects of Ni
on the acetylation of lysine residues near the
His residue (50).
The natural biochemistry of Ni suggests
that only the H3 site can possibly give rise to
Ni(III/II) redox chemistry, because it is the
only site with a potential cysteinate ligand that
might lower the potential of this redox couple.
Even this site is not likely to stabilize
Ni(III/II) redox chemistry because there is
only a single cysteine present. This site is also
unlikely to inhibit lysine acetylation given that
the location of the H3 site is in the C-terminal
region. Further, the structural data regarding
histones (42–45) indicate that the site is not
very accessible to solvents or metals. Even
though metal-centered redox chemistry can be
ruled out for all but the H3 site, any of the
sites could potentially activate DNA or his-
tone proteins toward reaction with O2, as has
been suggested for the Ni site in acireductone
dioxygenase (51). Each of these sites presents a
unique set of ligands that could readily be dis-
tinguished by XAS provided that a homoge-
neous sample of a single Ni histone complex is
formed. However, because of its location in
the N-terminal domain, only the H4 site is
likely to give rise to the changes in histone
acetylation and DNA methylation that have
been observed in response to Ni exposure.
The metal-binding properties of synthetic
peptides that contain the –A15KRHRK– H4
target Ni binding site have been studied (52).
Stability constants determined for the
blocked peptide Ac–AKRHRK–Am show
that >80% of Ni present in a solution at
pH = 9 is bound in a single complex in solu-
tion. This complex is proposed to lead to a
planar, four-coordinate, low-spin Ni tetra-aza
complex formed via coordination of one His
imidazole and three amide N-donor atoms.
The XAS spectrum of the Ni complex of
the similar blocked peptide Ac–SGRGKG-
GKGLGKGGAKRHRKVL–Am, containing
22 residues beginning with the N-terminus
and containing the H4 His18 Ni-binding site,
prepared at pH = 9, is summarized in Figure 2
(53). The Ni K-edge XANES spectrum
reveals only a weak peak assigned to a 1s →
3d electronic transition [peak area = 2.6(5) ×
10–2 eV] and does not display a peak associ-
ated with a 1s →  4pz electronic transition that
is diagnostic for a planar, four-coordinate
geometry. Thus, the Ni complex that is
formed from this peptide under these condi-
tions is six coordinate. EXAFS analysis shows
that Ni has six O- or N-donors with an aver-
age Ni–O/N distance of 2.06(2) Å. The struc-
ture is consistent with four ligands being
derived from the peptide and two originating
from water. Multiple scattering analysis of
EXAFS arising from atoms in the second and
third coordination sphere of Ni (6) confirm
that one His ligand is bound to Ni [second
coordination sphere Ni–C distances averaging
3.12(5) Å, third coordination sphere Ni–C/N
distances at an average of 4.26(5) Å].
Future studies are planned comparing the
structure of Ni bound to histone H4 with
those of this model and expectations based on
other possible binding sites.
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53. The 22-residue peptide Ac–SGRGKGGKGLGKG-
GAKRHRKVL–Am was synthesized on a solid support with
a 9050 Plus Synthesizer by BBM Inc. (Woburn, MA, USA)
using a conventional 9-fluorenylmethoxycarbonyl (Fmoc)
chemistry methodology starting from the C-terminal to the
N-terminal. N-Fmoc–protected amino acids and all other
peptide synthesis reagents were obtained from PE
Biosystems (Applied Biosystems, Foster City, CA, USA).
The peptide was puriﬁed using semipreparative high-per-
formance liquid chromatography (HPLC) on a C18 column
(Varian, Inc., Palo Alto, CA, USA) eluting with 0.1%
CF3COOH–H2O (solvent A) and 0.1% CF3COOH–CH3CN (sol-
vent B) (Sigma-Aldrich S.r.l., Milano, Italy), linear gradient
0–100% B over 50 min at a 3 mL/min ﬂow rate, with detec-
tion at 220 nm absorption used as a means of detection
(Varian Vacuum Technologies, Torino, Italy). The purity of
the peptide was checked by reverse-phase HPLC using a
C18 5-µm 100A microsorb-MV analytical column (Alltech
Associates, Inc., Deerﬁeld, IL, USA) (4.6 mm × 25 cm; ﬂow
rate, 1 mL/min), gradient 0–50% in 25 min (solvent A, 0.1%
CF3COOH–H2O), 50–100% in 35 min (solvent B, 0.1%
CH3CN–H2O). The molecular weight of the peptide was
confirmed by mass spectral analysis (MALDI.TOF.VOY-
AGER (PE Biosystems/Perseptive, Framingham, MA, USA).
The Ni–peptide complex for XAS analysis was prepared
by dissolving the peptide in deionized water containing 20%
glycerol and adding solution containing NiCl2 so that a 1:1
ratio of NiCl2/peptide was achieved. The pH of this solution
was adjusted to pH 9.4 by adding a dilute solution of NaOH.
The concentration of the Ni–peptide complex in the sample
studied was approximately 4.0 mM. The electronic absorp-
tion spectrum obtained on this sample was similar to pub-
lished values for the analogous hexapeptide (52).
Approximately 60 µL of the Ni-peptide solution was
transferred to a polycarbonate sample holder, and frozen
in liquid nitrogen. XAS data were collected at beam line
X9B at the National Synchrotron Light Source, Brookhaven
National Laboratories (Brookhaven, New York, USA). The
polycarbonate sample holder was inserted into a slotted
aluminum holder, held at 50 K. A focused X-ray beam was
used, with the vertical primary slit closed down (0.2 mm) to
maximize resolution in the XANES region, and opened up
(1.0 mm) for intensity in the EXAFS region. The monochro-
mator was internally calibrated to the ﬁrst inﬂection point
of Ni foil (8331.6 eV). X-ray fluorescence data were col-
lected using a 13-element detector (Canberra, Meriden,
CT, USA), and sample integrity was determined by moni-
tored the Ni K-edge energy on sequential scans. No
change in redox state or ligand environment was
observed. XAS data were analyzed in analogy with previ-
ously published procedures (6) with the addition that the
histidine multiple scattering pathways arising from the
coordinating imidazole were correlated to the respective
single scattering distances. A Fourier transform range of
2.0–12.5 Å-1 and back-transform limits of 1.1–4.2 Å were
used to Fourier-ﬁlter the data arising from the ﬁrst coordi-
nation sphere and histidine atoms.
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